Understanding/VBG
Disease/NN
Susceptibility/NN
through/IN
Population/NN
Genomics/NNS
./.
====================
Genetic/JJ
epidemiology/NN
studies/NNS
have/VBP
established/VBN
that/IN
the/DT
natural/JJ
variation/NN
of/IN
gene/NN
expression/NN
profiles/NNS
is/VBZ
heritable/JJ
and/CC
has/VBZ
genetic/JJ
bases/NNS
./.
====================
A/DT
number/NN
of/IN
proximal/JJ
and/CC
remote/VBP
DNA/NN
variations/NNS
,/,
known/VBN
as/IN
expression/NN
quantitative/JJ
trait/NN
loci/NNS
(/(
eQTLs/NNS
)/)
,/,
that/DT
are/VBP
associated/VBN
with/IN
the/DT
expression/NN
phenotypes/NNS
have/VBP
been/VBN
identified/VBN
,/,
first/JJ
in/IN
Epstein-Barr/JJ
virus-transformed/JJ
lymphoblastoid/JJ
cell/NN
lines/NNS
and/CC
later/RB
expanded/VBN
to/TO
other/JJ
cell/NN
and/CC
tissue/NN
types/NNS
./.
====================
Integration/NN
of/IN
the/DT
eQTL/NN
information/NN
and/CC
the/DT
network/NN
analysis/NN
of/IN
transcription/NN
modules/NNS
may/MD
lead/VB
to/TO
a/DT
better/RBR
understanding/NN
of/IN
gene/NN
expression/NN
regulation/NN
./.
====================
As/IN
these/DT
network/NN
modules/NNS
have/VBP
relevance/NN
to/TO
biological/JJ
or/CC
disease/NN
pathways/NNS
,/,
these/DT
findings/NNS
may/MD
be/VB
useful/JJ
in/IN
predicting/VBG
disease/NN
susceptibility/NN
./.
====================
Genetic/JJ
epidemiology/NN
is/VBZ
the/DT
study/NN
of/IN
the/DT
role/NN
of/IN
genetic/JJ
factors/NNS
in/IN
determining/VBG
health/NN
and/CC
disease/NN
in/IN
families/NNS
and/CC
in/IN
populations/NNS
and/CC
the/DT
interplay/NN
of/IN
such/JJ
genetic/JJ
factors/NNS
with/IN
environmental/JJ
factors/NNS
[/(
1/CD
]/)
./.
====================
Depending/VBG
on/IN
the/DT
number/NN
of/IN
genetic/JJ
factors/NNS
that/WDT
contribute/VBP
to/TO
pathogenicity/NN
,/,
genetic/JJ
diseases/NNS
are/VBP
categorized/VBN
into/IN
two/CD
classes/NNS
./.
====================
A/DT
so-called/JJ
monogenic/JJ
disorder/NN
is/VBZ
usually/RB
caused/VBD
by/IN
a/DT
single/JJ
gene/NN
mutation/NN
and/CC
has/VBZ
been/VBN
the/DT
subject/JJ
of/IN
intense/JJ
gene/NN
hunting/VBG
studies/NNS
using/VBG
familial/JJ
linkages/NNS
,/,
totaling/VBG
to/TO
more/RBR
than/IN
4,000/CD
diseases/NNS
being/VBG
linked/VBN
to/TO
causal/JJ
mutations/NNS
[/(
2/CD
]/)
./.
====================
Completion/NN
of/IN
the/DT
Human/JJ
Genome/NN
Project/NN
expedited/VBN
the/DT
studies/NNS
of/IN
not/RB
only/RB
monogenic/JJ
diseases/NNS
but/CC
also/RB
complex/NN
diseases/NNS
./.
====================
The/DT
latter/JJ
,/,
also/RB
called/VBN
polygenic/JJ
or/CC
multifactorial/JJ
diseases/NNS
,/,
are/VBP
contributed/VBN
by/IN
a/DT
number/NN
of/IN
genetic/JJ
factors/NNS
of/IN
relatively/RB
smaller/JJR
effects/NNS
./.
====================
Unlike/IN
monogenic/JJ
disorders/NNS
that/DT
often/RB
affect/VB
only/RB
a/DT
small/JJ
portion/NN
of/IN
a/DT
population/NN
and/CC
are/VBP
consequently/RB
rarely/RB
observed/VBN
,/,
polygenic/JJ
diseases/NNS
are/VBP
usually/RB
frequently/RB
observed/VBN
in/IN
a/DT
population/NN
and/CC
are/VBP
also/RB
termed/VBN
common/JJ
diseases/NNS
./.
====================
Chronic/JJ
diseases/NNS
,/,
such/JJ
as/IN
cancer/NN
,/,
diabetes/VBZ
,/,
hypertension/NN
,/,
and/CC
so/RB
on/IN
,/,
belong/IN
to/TO
this/DT
category/NN
./.
====================
The/DT
Human/JJ
Genome/NN
Project/NN
paved/JJ
the/DT
way/NN
to/TO
cataloging/VBG
common/JJ
variants/NNS
in/IN
the/DT
human/JJ
genome/NN
./.
====================
The/DT
International/JJ
HapMap/NN
Project/JJ
is/VBZ
a/DT
global/JJ
collaboration/NN
to/TO
map/VB
single-nucleotide/JJ
polymorphisms/NNS
(/(
SNPs/NNS
)/)
in/IN
the/DT
human/JJ
genome/NN
and/CC
to/TO
construct/VB
haplotype/NN
maps/VBZ
that/DT
show/VBP
which/WDT
allele/NN
of/IN
a/DT
locus/NN
co-occur/NN
with/IN
which/WDT
allele/NN
of/IN
another/DT
locus/NN
./.
====================
Using/VBG
three/CD
representative/JJ
continental/JJ
populations-that/NN
is/VBZ
,/,
Africans/NNS
,/,
Europeans/NNS
,/,
and/CC
Asians-the/DT
international/JJ
consortium/NN
cataloged/VBD
roughly/RB
1/CD
SNP/NN
for/IN
every/RB
300/CD
bp/NN
of/IN
the/DT
human/JJ
genome/NN
./.
====================
The/DT
information/NN
of/IN
position/NN
,/,
frequency/NN
,/,
and/CC
correlation/NN
structure/NN
,/,
called/VBN
linkage/NN
disequilibrium/NN
of/IN
these/DT
SNPs/NNS
,/,
has/VBZ
enabled/VBN
us/PRP
to/TO
design/VB
high-density/JJ
SNP/NN
chips/NNS
that/DT
can/MD
measure/VB
the/DT
genotypes/NNS
of/IN
fractions/NNS
of/IN
those/DT
SNPs/NNS
all/DT
at/IN
once/RB
and/CC
infer/VBP
the/DT
genetic/JJ
make-up/VBP
of/IN
the/DT
major/JJ
portion/NN
of/IN
the/DT
whole/JJ
genome/NN
./.
====================
Using/VBG
these/DT
chips/NNS
,/,
genotypes/NNS
of/IN
families/NNS
or/CC
unrelated/JJ
populations/NNS
are/VBP
measured/VBN
,/,
and/CC
the/DT
loci/NNS
displaying/VBG
statistically/RB
significantly/RB
different/JJ
frequency/NN
patterns/NNS
between/IN
disease-affected/JJ
and/CC
unaffected/JJ
groups/NNS
are/VBP
sought/VBN
./.
====================
Individuals/NNS
harboring/VBG
such/JJ
alleles/NNS
may/MD
have/VB
a/DT
higher/JJR
or/CC
lower/JJR
disease/NN
susceptibility/NN
than/IN
control/NN
groups/NNS
./.
====================
Scanning/VBG
genome-wide/NN
associations/NNS
of/IN
genotype-phenotype/JJ
relationships/NNS
is/VBZ
called/VBN
a/DT
genome-wide/JJ
association/NN
study/NN
(/(
GWAS/NN
)/)
and/CC
has/VBZ
become/VBN
extremely/RB
popular/JJ
,/,
reporting/VBG
more/RBR
than/IN
1,000/CD
papers/NNS
within/IN
the/DT
last/JJ
5-6/CD
years/NNS
[/(
3/CD
]/)
,/,
probably/RB
due/JJ
to/TO
the/DT
hypothesis-free/JJ
nature/NN
of/IN
its/PRP$
study/NN
design/NN
./.
====================
While/IN
GWASs/NNS
have/VBP
been/VBN
applied/VBN
to/TO
studies/NNS
of/IN
disease/NN
gene/NN
hunting/VBG
,/,
they/PRP
are/VBP
also/RB
well/RB
suited/VBN
to/TO
interrogating/VBG
genes/NNS
affecting/VBG
heritable/JJ
phenotypes/NNS
,/,
such/JJ
as/IN
height/RB
,/,
obesity/NN
,/,
plasma/NN
glucose/NN
concentration/NN
,/,
blood/NN
pressure/NN
,/,
bone/NN
density/NN
,/,
and/CC
so/RB
on/IN
./.
====================
Unlike/IN
disease/NN
studies/NNS
where/WRB
samples/NNS
are/VBP
segregated/VBN
into/IN
case/NN
and/CC
control/NN
groups/NNS
,/,
these/DT
phenotypes/NNS
display/VBP
a/DT
continuous/JJ
spectrum/NN
of/IN
values/NNS
in/IN
normal/JJ
populations/NNS
./.
====================
For/IN
s/NNS
uch/RB
a/DT
quantitative/JJ
trait/NN
,/,
its/PRP$
statistical/JJ
correlation/NN
with/IN
the/DT
genotypes/NNS
within/IN
a/DT
population/NN
is/VBZ
sought/VBN
,/,
instead/RB
of/IN
dichotomizing/VBG
the/DT
samples/NNS
into/IN
case/NN
and/CC
control/NN
groups/NNS
./.
====================
The/DT
genomic/JJ
loci/NNS
that/IN
show/VBP
correlations/NNS
with/IN
such/JJ
a/DT
trait/NN
are/VBP
called/VBN
quantitative/JJ
trait/NN
loci/NNS
(/(
QTLs/NNS
)/)
./.
====================
According/VBG
to/TO
the/DT
current/JJ
estimate/NN
,/,
the/DT
human/JJ
genome/NN
harbors/VBZ
around/IN
22,000/CD
genes/NNS
and/CC
200,000/CD
mRNA/NN
transcripts/NNS
[/(
4/CD
]/)
./.
====================
One/CD
way/NN
that/DT
variations/NNS
in/IN
the/DT
genomic/JJ
sequence/NN
can/MD
exert/VB
phenotypic/JJ
differences/NNS
is/VBZ
through/IN
the/DT
alteration/NN
of/IN
structure/NN
and/CC
function/NN
of/IN
the/DT
gene/NN
products/NNS
./.
====================
Genetic/JJ
variation/NN
may/MD
also/RB
result/VBP
in/IN
changes/NNS
in/IN
the/DT
expression/NN
levels/NNS
of/IN
products/NNS
and/CC
,/,
thereby/RB
,/,
their/PRP$
activities/NNS
./.
====================
Since/IN
most/JJS
SNPs/NNS
identified/VBN
through/IN
GWASs/NNS
do/VBP
change/NN
the/DT
amino/NN
acid/NN
sequence/NN
of/IN
a/DT
protein/NN
,/,
large/JJ
portions/NNS
of/IN
the/DT
genetic/JJ
variation/NN
may/MD
be/VB
regulatory/JJ
in/IN
nature/NN
./.
====================
Differences/NNS
in/IN
gene/NN
expression/NN
profiles/NNS
between/IN
individuals/NNS
then/RB
become/VBP
molecular/JJ
and/CC
intermediate/JJ
phenotypes/NNS
that/IN
in/IN
turn/NN
induce/VBP
changes/NNS
in/IN
higher-order/JJ
disease/NN
traits/VBZ
[/(
5/CD
]/)
./.
====================
In/IN
fact/NN
,/,
Cheung/NN
et/FW
al/JJ
./.
====================
[/(
6/CD
]/)
observed/VBN
some/DT
genes/NNS
showing/VBG
markedly/RB
different/JJ
expression/NN
levels/NNS
between/IN
individuals/NNS
and/CC
familial/JJ
aggregation/NN
of/IN
expression/NN
phenotypes/NNS
./.
====================
In/IN
their/PRP$
follow-up/JJ
study/NN
using/VBG
14/CD
large/JJ
families/NNS
,/,
they/PRP
also/RB
identified/VBD
approximately/RB
1,000/CD
expression/NN
phenotypes/NNS
that/IN
showed/VBD
significant/JJ
evidence/NN
of/IN
linkage/NN
to/TO
specific/JJ
chromosomal/JJ
regions/NNS
[/(
7/CD
]/)
./.
====================
Dixon/NN
et/FW
al/JJ
./.
====================
[/(
8/CD
]/)
also/RB
observed/VBN
heritable/JJ
expression/NN
patterns/NNS
in/IN
about/RB
30/CD
%/NN
of/IN
the/DT
genes/NNS
and/CC
transcripts/NNS
of/IN
their/PRP$
probes/NNS
and/CC
identified/VBD
the/DT
genomic/JJ
regions/NNS
where/WRB
the/DT
genotypes/NNS
were/VBD
associated/VBN
with/IN
those/DT
expression/NN
phenotypes/NNS
./.
====================
These/DT
are/VBP
termed/VBN
expression/NN
QTL/NN
(/(
eQTL/NN
)/)
and/CC
can/MD
be/VB
proximal/JJ
(/(
cis/NN
)/)
or/CC
distal/JJ
(/(
trans/NNS
)/)
to/TO
the/DT
gene/NN
of/IN
expression/NN
variation/NN
(/(
Fig/NN
./.
====================
1/CD
)/)
./.
====================
Other/JJ
species/NNS
also/RB
show/VBP
eQTL/NN
./.
====================
For/IN
example/NN
,/,
eQTLs/NNS
have/VBP
been/VBN
observed/VBN
in/IN
recombinant/JJ
inbred/JJ
mouse/NN
strains/NNS
[/(
9-11/CD
]/)
,/,
yeast/NN
[/(
12/CD
,/,
13/CD
]/)
,/,
and/CC
plants/NNS
[/(
14/CD
]/)
./.
====================
The/DT
B-lymphoblastoid/JJ
cell/NN
lines/NNS
established/VBN
by/IN
the/DT
International/JJ
HapMap/NN
Project/JJ
provide/VBP
invaluable/JJ
resources/VBZ
for/IN
the/DT
study/NN
of/IN
eQTL/NN
:/:
for/IN
these/DT
samples/NNS
,/,
matched/VBN
genotypes/NNS
and/CC
expression/NN
profiles/NNS
are/VBP
publicly/RB
available/JJ
./.
====================
It/PRP
is/VBZ
well/RB
known/VBN
that/IN
genome-wide/VBP
genotype/NN
profiles/NNS
have/VBP
the/DT
power/NN
to/TO
discriminate/VB
continental/JJ
populations/NNS
./.
====================
Principal/JJ
component/NN
analysis/NN
of/IN
the/DT
genotypes/NNS
of/IN
the/DT
HapMap/NN
populations/NNS
clearly/RB
clusters/NNS
the/DT
individuals/NNS
according/VBG
to/TO
their/PRP$
population/NN
origins/NNS
[/(
15/CD
]/)
./.
====================
On/IN
the/DT
other/JJ
hand/NN
,/,
it/PRP
appears/VBZ
that/IN
the/DT
population/NN
difference/NN
in/IN
expression/NN
levels/NNS
is/VBZ
negligible/JJ
[/(
16/CD
]/)
or/CC
very/RB
small/JJ
[/(
17/CD
]/)
./.
====================
For/IN
example/NN
,/,
the/DT
expression/NN
levels/NNS
averaged/VBD
over/IN
each/DT
population/NN
are/VBP
highly/RB
correlated/VBD
between/IN
populations/NNS
(/(
Fig/NN
./.
====================
2/CD
)/)
./.
====================
Apparently/RB
,/,
the/DT
within-group/NN
expression/NN
variance/NN
is/VBZ
much/RB
larger/JJR
than/IN
the/DT
between-group/NN
variance/NN
./.
====================
This/DT
is/VBZ
perhaps/RB
due/JJ
to/TO
the/DT
fact/NN
that/IN
unlike/IN
genotypes/NNS
that/IN
can/MD
drift/VB
somewhat/RB
freely/RB
without/IN
functional/JJ
alteration/NN
,/,
gene/NN
expression/NN
levels/NNS
are/VBP
tightly/RB
regulated/VBN
by/IN
complex/NN
genetic/JJ
programs/NNS
./.
====================
Instead/RB
of/IN
focusing/VBG
on/IN
population/NN
differences/NNS
in/IN
expression/NN
levels/NNS
,/,
intense/JJ
effort/NN
has/VBZ
been/VBN
made/VBN
to/TO
cataloging/VBG
eQTLs/NNS
and/CC
classifying/VBG
them/PRP
into/IN
cis/NN
and/CC
trans/JJ
./.
====================
For/IN
example/NN
,/,
using/VBG
the/DT
HapMap/NN
samples/NNS
of/IN
European/JJ
and/CC
African/JJ
ancestry/NN
,/,
Duan/JJ
et/FW
al/JJ
./.
====================
[/(
18/CD
]/)
found/VBN
about/IN
5,000/CD
expression/NN
quantitative/JJ
nucleotides/NNS
(/(
eQTNs/NNS
)/)
in/IN
each/DT
population/NN
./.
====================
They/PRP
used/VBN
4/CD
Mb/NN
of/IN
distance/NN
between/IN
the/DT
gene/NN
and/CC
SNP/NN
as/IN
the/DT
criteria/NNS
for/IN
classifying/VBG
local/JJ
and/CC
distant/JJ
eQTNs/NNS
and/CC
observed/VBN
that/IN
genes/NNS
harboring/VBG
distant/JJ
eQTNs/NNS
were/VBD
enriched/VBN
with/IN
functions/NNS
,/,
like/IN
transmembrane/JJ
signal/NN
transduction/NN
,/,
implying/VBG
roles/NNS
in/IN
gene/NN
expression/NN
regulation/NN
[/(
18/CD
]/)
./.
====================
Stranger/NN
et/FW
al/JJ
./.
====================
[/(
17/CD
]/)
used/VBN
all/DT
270/CD
HapMap/NN
samples/NNS
to/TO
identify/VB
at/IN
least/JJS
1,348/CD
and/CC
180/CD
genes/NNS
showing/VBG
cis/NN
and/CC
trans/JJ
association/NN
signals/NNS
,/,
respectively/RB
./.
====================
Their/PRP$
result/NN
is/VBZ
in/IN
sharp/JJ
contrast/NN
to/TO
the/DT
previous/JJ
estimate/NN
that/DT
counts/NNS
most/JJS
eQTLs/NNS
as/IN
trans/JJ
rather/RB
than/IN
cis/NN
[/(
7/CD
]/)
./.
====================
Veyrieras/NNS
et/FW
al/JJ
./.
====================
[/(
19/CD
]/)
reanalyzed/VBD
the/DT
HapMap/NN
data/NNS
using/VBG
a/DT
sophisticated/JJ
Bayesian/JJ
hierarchical/JJ
model/NN
to/TO
resolve/VB
the/DT
eQTLs/NNS
at/IN
a/DT
fine/JJ
scale/NN
:/:
most/JJS
eQTLs/NNS
lay/RB
either/CC
within/IN
genes/NNS
or/CC
close/JJ
to/TO
genes/NNS
(/(
</JJR
20/CD
kb/NN
)/)
;/:
eQTLs/NNS
were/VBD
enriched/VBN
around/IN
transcription/NN
start/NN
sites/NNS
and/CC
250/CD
bp/NN
upstream/RB
of/IN
transcription/NN
end/NN
sites/NNS
,/,
and/CC
exons/NNS
were/VBD
more/RBR
likely/RB
to/TO
be/VB
eQTLs/NNS
than/IN
introns/NNS
./.
====================
Their/PRP$
finding/NN
of/IN
enriched/JJ
eQTLs/NNS
upstream/RB
of/IN
transcription/NN
end/NN
sites/NNS
is/VBZ
interesting/JJ
,/,
in/IN
that/DT
this/DT
site/NN
is/VBZ
related/JJ
to/TO
post-transcriptional/JJ
control/NN
and/CC
mRNA/NN
stability/NN
./.
====================
This/DT
underscores/VBZ
the/DT
important/JJ
role/NN
of/IN
mRNA/NN
stability/NN
besides/VBZ
transcription/NN
initiation/NN
in/IN
determining/VBG
steady-state/JJ
mRNA/NN
levels/NNS
[/(
19/CD
]/)
./.
====================
The/DT
presence/NN
of/IN
cis-acting/JJ
eQTLs/NNS
for/IN
a/DT
gene/NN
implies/VBZ
that/IN
these/DT
alleles/NNS
have/VBP
different/JJ
transcription/NN
levels/NNS
or/CC
allelespecific/JJ
expression/NN
./.
====================
The/DT
typical/JJ
microarray/NN
chips/NNS
designed/VBN
for/IN
expression/NN
measurement/NN
do/VBP
not/RB
usually/RB
distinguish/VBP
minute/JJ
sequence/NN
differences/NNS
of/IN
the/DT
SNP/NN
alleles/NNS
residing/VBG
within/IN
a/DT
transcript/NN
./.
====================
One/CD
can/MD
infer/VB
the/DT
allele-specific/JJ
expression/NN
using/VBG
statistical/JJ
tests/NNS
that/IN
model/NN
the/DT
expression/NN
levels/NNS
of/IN
a/DT
gene/NN
with/IN
the/DT
number/NN
of/IN
minor/JJ
alleles/NNS
at/IN
each/DT
locus/NN
./.
====================
On/IN
the/DT
other/JJ
hand/NN
,/,
by/IN
hybridizing/VBG
the/DT
transcripts/NNS
onto/IN
SNP/NN
chips/NNS
or/CC
directly/RB
sequencing/NN
the/DT
transcripts/NNS
,/,
one/CD
can/MD
validate/VB
the/DT
allele-specific/JJ
expression/NN
./.
====================
Ge/NN
et/FW
al/JJ
./.
====================
[/(
20/CD
]/)
used/VBN
Illumina/NN
Human/JJ
1M/NN
Beadchips/NNS
to/TO
measure/VB
allele-specific/JJ
expression/NN
in/IN
53/CD
lymphoblastoid/JJ
cell/NN
lines/NNS
derived/VBN
from/IN
European/JJ
descendants/NNS
./.
====================
With/IN
the/DT
advent/JJ
of/IN
next-generation/NN
sequencing/NN
technologies/NNS
,/,
RNA-seq/NN
has/VBZ
become/VBN
popular/JJ
and/CC
has/VBZ
been/VBN
applied/VBN
to/TO
detecting/VBG
allele-specific/JJ
expression/NN
./.
====================
Pickrell/NN
et/FW
al/JJ
./.
====================
[/(
21/CD
]/)
sequenced/VBN
RNA/NN
from/IN
69/CD
lymphoblastoid/JJ
cell/NN
lines/NNS
derived/VBN
from/IN
unrelated/JJ
African/JJ
individuals/NNS
who/WP
participated/JJ
in/IN
the/DT
International/JJ
HapMap/NN
Project/JJ
,/,
discovering/VBG
a/DT
number/NN
of/IN
eQTLs/NNS
involved/VBN
in/IN
allele-specific/JJ
expression/NN
or/CC
allele-specific/JJ
splicing/NN
./.
====================
So/RB
far/RB
,/,
most/JJS
eQTL/NN
studies/NNS
have/VBP
examined/VBN
expression-genotype/NN
relations/NNS
in/IN
lymphoblastoid/JJ
cell/NN
lines/NNS
./.
====================
Since/IN
many/JJ
genes/NNS
display/VBP
tissue-specific/JJ
expression/NN
patterns/NNS
,/,
one/CD
may/MD
argue/VB
that/IN
the/DT
expression-genotype/NN
relations/NNS
observed/VBN
in/IN
Epstein-Barr/JJ
virus-transformed/JJ
lymphoblastoid/JJ
cell/NN
lines/NNS
may/MD
not/RB
be/VB
preserved/VBN
in/IN
other/JJ
tissues/NNS
or/CC
cell/NN
types/NNS
./.
====================
Gerrits/NNS
et/FW
al/JJ
./.
====================
[/(
22/CD
]/)
observed/VBN
that/IN
eQTLs/NNS
were/VBD
quite/RB
different/JJ
,/,
depending/VBG
on/IN
the/DT
differentiation/NN
status/NN
of/IN
the/DT
cells/NNS
,/,
suggesting/VBG
uncommon/JJ
functional/JJ
regulatory/JJ
networks/NNS
among/IN
different/JJ
cell/NN
types/NNS
./.
====================
Nica/NN
et/FW
al/JJ
./.
====================
[/(
23/CD
]/)
compared/VBN
cis-regulatory/JJ
eQTLs/NNS
from/IN
three/CD
different/JJ
tissues/NNS
of/IN
co-twin/NN
samples/NNS
from/IN
the/DT
MuTHER/NN
project/VB
(/(
http/NN
:/:
//www.muther.ac.uk//JJ
)/)
,/,
observing/VBG
30/CD
%/NN
shared/VBN
eQTLs/NNS
,/,
29/CD
%/NN
exclusively/RB
tissue-specific/JJ
eQTLs/NNS
,/,
and/CC
substantial/JJ
differences/NNS
in/IN
expression/NN
levels/NNS
in/IN
different/JJ
tissues/NNS
./.
====================
In/IN
addition/NN
to/TO
the/DT
similar/JJ
proportion/NN
of/IN
exclusively/RB
tissue-specific/JJ
cis-regulatory/JJ
eQTLs/NNS
from/IN
five/CD
different/JJ
tissues/NNS
,/,
Fu/NNP
et/FW
al/JJ
./.
====================
[/(
24/CD
]/)
also/RB
observed/VBN
many/JJ
examples/NNS
of/IN
alternative/JJ
regulation/NN
,/,
where/WRB
a/DT
gene/NN
is/VBZ
cis-associated/JJ
with/IN
different/JJ
SNPs/NNS
,/,
depending/VBG
on/IN
the/DT
tissue/NN
./.
====================
If/IN
one/CD
were/VBD
to/TO
use/VB
eQTL/NN
information/NN
in/IN
predicting/VBG
disease/NN
susceptibility/NN
,/,
it/PRP
is/VBZ
thus/RB
imperative/VBP
to/TO
understand/VB
expression-genotype/NN
relations/NNS
in/IN
the/DT
tissue/NN
of/IN
interest/NN
,/,
not/RB
just/RB
in/IN
lymphoblastoid/JJ
cell/NN
lines/NNS
[/(
25/CD
]/)
./.
====================
When/WRB
transcript/NN
expression/NN
levels/NNS
were/VBD
measured/VBN
in/IN
adipose/JJ
tissues/NNS
as/IN
well/RB
as/IN
blood/NN
in/IN
large/JJ
population/NN
cohorts/NNS
,/,
unlike/IN
expression/NN
profiles/NNS
in/IN
blood/NN
,/,
a/DT
marked/JJ
correlation/NN
between/IN
expression/NN
levels/NNS
in/IN
adipose/JJ
tissues/NNS
and/CC
obesity-related/VBN
traits/VBZ
was/VBD
observed/VBN
[/(
26/CD
]/)
./.
====================
Schadt/NN
et/FW
al/JJ
./.
====================
[/(
5/CD
]/)
observed/VBN
over/IN
6,000/CD
associations/NNS
between/IN
genotypes/NNS
and/CC
expression/NN
in/IN
400/CD
human/JJ
liver/NN
samples/NNS
to/TO
understand/VB
the/DT
genetic/JJ
architecture/NN
of/IN
gene/NN
expression/NN
in/IN
the/DT
human/JJ
liver/NN
,/,
a/DT
metabolically/RB
important/JJ
tissue/NN
involved/VBN
in/IN
various/JJ
common/JJ
diseases/NNS
,/,
such/JJ
as/IN
obesity/NN
,/,
cancer/NN
,/,
diabetes/VBZ
,/,
and/CC
atherosclerosis/NN
./.
====================
We/PRP
have/VBP
reviewed/VBN
above/JJ
that/DT
natural/JJ
variation/NN
in/IN
gene/NN
expression/NN
is/VBZ
substantial/JJ
and/CC
heritable/JJ
./.
====================
Genetic/JJ
analyses/NNS
of/IN
expression/NN
phenotypes/NNS
have/VBP
identified/VBN
cis-/JJ
and/CC
trans-associated/VBD
loci/NNS
,/,
culminating/VBG
in/IN
our/PRP$
understanding/NN
of/IN
gene/NN
expression/NN
regulation/NN
./.
====================
One/CD
should/MD
understand/VB
that/DT
not/RB
all/DT
genes/NNS
showing/VBG
natural/JJ
variation/NN
are/VBP
regulated/VBN
by/IN
either/CC
cis-/JJ
or/CC
trans-eQTLs/NNS
./.
====================
For/IN
example/NN
,/,
genes/NNS
downstream/JJ
of/IN
eQTL-regulated/JJ
genes/NNS
in/IN
a/DT
regulatory/JJ
network/NN
may/MD
also/RB
show/VBP
natural/JJ
variation/NN
./.
====================
If/IN
they/PRP
are/VBP
regulated/VBN
primarily/RB
by/IN
a/DT
regulator/NN
,/,
their/PRP$
expression/NN
profile/NN
may/MD
resemble/VB
that/DT
of/IN
the/DT
regulator/NN
./.
====================
On/IN
the/DT
other/JJ
hand/NN
,/,
if/IN
multiple/JJ
regulators/NNS
are/VBP
involved/VBN
,/,
the/DT
downstream/JJ
target/NN
genes/NNS
may/MD
show/VB
complex/NN
expression/NN
profiles/NNS
that/DT
may/MD
look/VB
independent/JJ
of/IN
those/DT
of/IN
the/DT
regulators/NNS
./.
====================
Integrating/VBG
the/DT
bioinformatic/JJ
learning/VBG
of/IN
regulatory/JJ
programs/NNS
and/CC
genetic/JJ
analysis/NN
of/IN
cis-/JJ
and/CC
trans-acting/JJ
DNA/NN
variants/NNS
may/MD
lead/VB
to/TO
a/DT
better/RBR
understanding/NN
of/IN
gene/NN
expression/NN
regulation/NN
[/(
27/CD
]/)
./.
====================
Nayak/NN
et/FW
al/JJ
./.
====================
[/(
28/CD
]/)
constructed/VBN
co-expression/NN
networks/NNS
based/VBN
on/IN
the/DT
HapMap/NN
expression/NN
profiles/NNS
of/IN
African/JJ
,/,
European/JJ
,/,
and/CC
Asian/JJ
ancestries/NNS
,/,
discovering/VBG
that/DT
the/DT
subnetwork/NN
structures/NNS
are/VBP
not/RB
random/JJ
but/CC
relevant/JJ
to/TO
biological/JJ
pathways/NNS
or/CC
disease/NN
susceptibility/NN
./.
====================
This/DT
implies/VBZ
that/IN
genes/NNS
are/VBP
regulated/VBN
by/IN
a/DT
common/JJ
set/NN
of/IN
regulatory/JJ
modules/NNS
and/CC
that/IN
the/DT
variable/JJ
activity/NN
of/IN
the/DT
modules/NNS
due/JJ
to/TO
genetic/JJ
variation/NN
can/MD
result/VB
in/IN
clustered/VBN
expression/NN
profiles/NNS
of/IN
the/DT
target/NN
genes/NNS
./.
====================
Li/NNS
et/FW
al/JJ
./.
====================
[/(
9/CD
]/)
,/,
using/VBG
32/CD
recombinant/JJ
inbred/JJ
mouse/NN
strains/NNS
,/,
reported/VBD
29/CD
transcription/NN
modules/NNS
and/CC
their/PRP$
associations/NNS
with/IN
18/CD
classical/JJ
physiological/JJ
and/CC
behavioral/JJ
traits/VBZ
,/,
possibly/RB
through/IN
eQTLs/NNS
./.
====================
Individual/JJ
variation/NN
in/IN
gene/NN
expression/NN
levels/NNS
may/MD
be/VB
influenced/VBN
by/IN
environmental/JJ
and/CC
genetic/JJ
factors/NNS
./.
====================
A/DT
substantial/JJ
proportion/NN
of/IN
the/DT
variation/NN
is/VBZ
heritable/JJ
and/CC
thus/RB
has/VBZ
a/DT
genetic/JJ
basis/NN
./.
====================
Based/VBN
on/IN
studies/NNS
on/IN
population-level/JJ
genotype-expression/NN
data/NNS
,/,
it/PRP
is/VBZ
now/RB
well/RB
established/VBN
that/IN
DNA/NN
variations/NNS
affect/VB
the/DT
expression/NN
levels/NNS
of/IN
nearby/JJ
or/CC
remote/VBP
genes/NNS
./.
====================
Since/IN
the/DT
genotype/NN
data/NNS
used/VBN
in/IN
these/DT
studies/NNS
were/VBD
mostly/RB
measured/VBN
on/IN
commercial/JJ
SNP/NN
chip/NN
platforms/NNS
of/IN
common/JJ
variants/NNS
,/,
the/DT
causal/JJ
eQTLs/NNS
must/MD
be/VB
probed/VBN
SNPs/NNS
or/CC
located/JJ
within/IN
the/DT
linkage/NN
disequilibrium/NN
blocks/VBZ
tagged/JJ
by/IN
the/DT
probed/JJ
SNPs/NNS
./.
====================
Whatever/RB
the/DT
case/NN
is/VBZ
,/,
one/CD
may/MD
wonder/VB
whether/IN
those/DT
eQTLs/NNS
evolved/VBD
neutrally/RB
without/IN
any/DT
selection/NN
pressure/NN
or/CC
whether/IN
they/PRP
were/VBD
the/DT
result/NN
of/IN
selection/NN
over/IN
human/JJ
population/NN
history/JJ
./.
====================
The/DT
co-expression/NN
network/NN
study/NN
by/IN
Nayak/NN
et/FW
al/JJ
./.
====================
[/(
28/CD
]/)
indicated/VBD
that/IN
the/DT
subnetworks/NNS
are/VBP
modular/JJ
and/CC
coherent/JJ
in/IN
biological/JJ
functions/NNS
./.
====================
It/PRP
is/VBZ
very/RB
unlikely/JJ
that/IN
such/JJ
network/NN
structures/NNS
were/VBD
derived/VBN
as/IN
the/DT
result/NN
of/IN
random/JJ
drift/JJ
in/IN
genomic/JJ
variations/NNS
./.
====================
It/PRP
is/VBZ
also/RB
interesting/VBG
that/IN
evolutionary/JJ
selection/NN
operated/JJ
on/IN
a/DT
network/NN
or/CC
pathway/NN
level/NN
./.
====================
Although/IN
they/PRP
must/MD
have/VBP
occurred/VBN
gene/NN
by/IN
gene/NN
,/,
the/DT
whole/JJ
sum/NN
of/IN
the/DT
variations/NNS
has/VBZ
biological/JJ
themes/NNS
./.
====================
If/IN
the/DT
activity/NN
of/IN
the/DT
pathways/NNS
is/VBZ
variable/JJ
between/IN
normal/JJ
individuals/NNS
,/,
it/PRP
has/VBZ
an/DT
implication/NN
in/IN
predicting/VBG
disease/NN
susceptibility/NN
./.
====================
As/IN
the/DT
subjects/NNS
probed/JJ
by/IN
gene/NN
expression/NN
profiling/VBG
are/VBP
normal/JJ
individuals/NNS
,/,
the/DT
variations/NNS
of/IN
the/DT
pathway/NN
activity/NN
may/MD
not/RB
be/VB
large/JJ
enough/IN
to/TO
trigger/VB
diseases/NNS
./.
====================
Nevertheless/RB
,/,
they/PRP
may/MD
predispose/VB
the/DT
genetic/JJ
background/NN
of/IN
an/DT
individual/JJ
to/TO
be/VB
susceptible/JJ
or/CC
resistant/JJ
to/TO
certain/JJ
diseases/NNS
./.
====================
For/IN
example/NN
,/,
individuals/NNS
having/VBG
slightly/RB
diminished/VBN
immune/JJ
pathway/NN
activities/NNS
may/MD
have/VB
a/DT
high/JJ
tendency/NN
of/IN
contracting/VBG
infectious/JJ
diseases/NNS
or/CC
other/JJ
immune-related/JJ
diseases/NNS
./.
====================
The/DT
next/JJ
challenge/NN
would/MD
then/RB
be/VB
the/DT
experimental/JJ
validation/NN
of/IN
this/DT
hypothesis/NN
./.
====================
The/DT
concept/NN
of/IN
expression/NN
quantitative/JJ
trait/NN
loci/NNS
(/(
eQTLs/NNS
)/)
./.
====================
If/IN
transcript/NN
abundance/NN
depends/VBZ
on/IN
the/DT
genotype/NN
of/IN
a/DT
genomic/JJ
locus/NN
,/,
such/JJ
a/DT
region/NN
is/VBZ
called/VBN
an/DT
eQTL/NN
./.
====================
If/IN
an/DT
eQTL/NN
is/VBZ
found/VBN
inside/IN
or/CC
near/JJ
the/DT
boundary/NN
of/IN
the/DT
target/NN
gene/NN
,/,
it/PRP
is/VBZ
classified/VBN
as/IN
cis-regulatory/JJ
(/(
A/DT
)/)
;/:
otherwise/RB
,/,
it/PRP
is/VBZ
trans-regulatory/JJ
(/(
B/NN
)/)
./.
====================
In/IN
the/DT
latter/JJ
case/NN
,/,
the/DT
expression/NN
level/NN
of/IN
a/DT
target/NN
gene/NN
is/VBZ
not/RB
regulated/VBN
by/IN
its/PRP$
cis-eQTL/NN
but/CC
through/IN
a/DT
regulator/NN
,/,
such/JJ
as/IN
a/DT
transcription/NN
factor/NN
(/(
TF/NN
)/)
,/,
whose/WP$
expression/NN
is/VBZ
regulated/VBN
by/IN
its/PRP$
cis-element/JJ
./.
====================
Comparison/NN
of/IN
average/JJ
expression/NN
levels/NNS
of/IN
all/DT
genes/NNS
between/IN
two/CD
ethnic/JJ
groups/NNS
./.
====================
The/DT
expression/NN
profile/NN
datasets/NNS
of/IN
the/DT
International/JJ
HapMap/NN
populations/NNS
(/(
European/NN
[/(
CEU/NN
]/)
and/CC
African/JJ
[/(
YRI/NN
]/)
)/)
measured/VBD
in/IN
lymphoblastoid/JJ
cell/NN
lines/NNS
were/VBD
downloaded/VBN
from/IN
Gene/NN
Expression/NN
Omnibus/FW
(/(
GEO/NN
accession/NN
no/DT
./.
====================
GSE6536/NN
)/)
./.
====================
For/IN
each/DT
of/IN
the/DT
19,723/CD
genes/NNS
,/,
the/DT
log-transformed/JJ
expression/NN
levels/NNS
of/IN
both/DT
60/CD
YRI/NN
and/CC
60/CD
CEU/NN
individuals/NNS
were/VBD
averaged/VBN
and/CC
plotted/JJ
on/IN
the/DT
x-/JJ
and/CC
y-axis/NN
,/,
respectively/RB
./.
====================
